Steris | STE - Debt


Steris reported $2.09B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
3M USD 12.55B 5M Jun/2026
Accuray USD 170.24M 4.52M Sep/2024
Baxter International USD 9.69B 93M Mar/2026
Becton, Dickinson and Co. USD 17.28B 2.26B Mar/2026
Boston Scientific USD 11.03B 407M Mar/2026
CONMED USD 860.87M 25.93M Mar/2026
Cooper Companies USD 2.46B 39.5M Mar/2026
Dexcom USD 1.24B 900K Mar/2026
Ecolab USD 9.27B 269M Mar/2026
Edwards Lifesciences USD 600M 105.4M Mar/2026
Fortive USD 3.51B 20.2M Jun/2026
Getinge SEK 10.73B 141M Dec/2024
Globus Medical USD 115.22M 3.43M Mar/2026
Haemonetics USD 1.22B 153K Mar/2026
Idexx Laboratories USD 1.1B 9.37M Jun/2026
Inogen USD 0 0 Jun/2022
Insulet USD 948.4M 300K Jun/2026
Integra LifeSciences USD 2.04B 6.27M Mar/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 54.99B 7.05B Mar/2026
Olympus JPY 233.87B 4.77B Sep/2025
Orthofix International USD 137.23M 338K Sep/2024
Owens Minor USD 1.95B 91.18M Mar/2025
ResMed USD 843.17M 4.55M Mar/2026
Steris USD 2.09B 33.5M Mar/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 132.16M Jun/2026
Teleflex USD 2.69B 39.95M Mar/2026
Thermo Fisher Scientific USD 43.16B 3.78B Mar/2026
Zimmer Biomet Holdings USD 7.48B 8M Jun/2026